দেশ: নেদারল্যান্ডস
ভাষা: ডাচ
সূত্র: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
PRAVASTATINE NATRIUM 40 mg/stuk
Stada Arzneimittel AG Stadastrasse 2-18 61118 BAD VILBEL (DUITSLAND)
C10AA03
PRAVASTATINE NATRIUM 40 mg/stuk
Filmomhulde tablet
CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; COPOVIDON (E 1208) ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROLOSE (E 463) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MAGNESIUMCARBONAAT, ZWAAR (E 504 (II)) ; MAGNESIUMSTEARAAT (E 470b) ; POLYETHYLEENGLYCOL (E 1521) ; SILICIUMDIOXIDE (E 551), CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROLOSE (E 463) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MAGNESIUMCARBONAAT, ZWAAR (E 504 (II)) ; MAGNESIUMSTEARAAT (E 470b) ; POLYETHYLEENGLYCOL (E 1521) ; SILICIUMDIOXIDE (E 551), CELLULOSE, MICROKRISTALLIJN (E 460) ; COPOVIDON ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROLOSE (E 463) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; LACTOSE 1-WATER ; MAGNESIUMCARBONAAT, ZWAAR (E 504 (II)) ; MAGNESIUMSTEARAAT (E 470b) ; POLYETHYLEENGLYCOL (E 1521) ; SILICIUMDIOXIDE (E 551),
Oraal gebruik
Pravastatin
Hulpstoffen: CELLULOSE, MICROKRISTALLIJN (E 460); COPOVIDON; CROSCARMELLOSE NATRIUM (E 468); HYPROLOSE (E 463); HYPROMELLOSE (E 464); IJZEROXIDE GEEL (E 172); LACTOSE 1-WATER; MAGNESIUMCARBONAAT, ZWAAR (E 504 (II)); MAGNESIUMSTEARAAT (E 470b); POLYETHYLEENGLYCOL (E 1521); SILICIUMDIOXIDE (E 551);
1900-01-01
PACKAGE LEAFLET: INFORMATION FOR THE USER PRAVASTATINE NA CF 10 MG FILM-COATED TABLETS PRAVASTATINE NA CF 20 MG FILM-COATED TABLETS PRAVASTATINE NA CF 40 MG FILM-COATED TABLETS pravastatin sodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Pravastatine Na CF is and what it is used for 2. What you need to know before you take Pravastatine Na CF 3. How to take Pravastatine Na CF 4. Possible side effects 5. How to store Pravastatine Na CF 6. Contents of the pack and other information 1. WHAT PRAVASTATINE NA CF IS AND WHAT IT IS USED FOR Pravastatin, the active substance of Pravastatine Na CF, belongs to a group of medicines called statins (or HMG-CoA reductase inhibitors). It prevents the production of cholesterol by the liver and consequently reduces the levels of cholesterol and other fats (triglycerides) in your body. When there are excessive levels of cholesterol in the blood, the cholesterol accumulates on the walls of blood vessels and blocks them. This condition is called hardening of the arteries or atherosclerosis and it may lead to: • chest pain (angina pectoris), when a blood vessel in the heart is partially blocked • a heart attack (myocardial infarction), when a blood vessel in the heart is completely blocked • a stroke (cerebrovascular accident), when a blood vessel in the brain is completely blocked This medicine is used in 3 situations: In the treatment of high levels of cholesterol and fats in the blood Pravastatine Na CF is used to lower high levels of "bad" cholesterol সম্পূর্ণ নথি পড়ুন
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Pravastatin Na CF 10 mg film-coated tablets Pravastatin Na CF 20 mg film-coated tablets Pravastatin Na CF 40 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg pravastatin sodium. Each tablet contains 20 mg pravastatin sodium. Each tablet contains 40 mg pravastatin sodium. Excipient(s) with known effect One film-coated tablet contains 52.15 mg lactose monohydrate. One film-coated tablet contains 104.60 mg lactose monohydrate. One film-coated tablet contains 207.36 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Film-coated tablet Pink-peach, indented capsule-shape tablet with “10” on one side._ _ Yellow, indented capsule-shape tablet with “20” on one side._ _ Yellow, indented capsule-shape tablet with “40” on one side._ _ The tablet can be divided into equal doses._ _ 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Primary prevention Reduction of cardiovascular mortality and morbidity in patients with moderate or severe hypercholesterolaemia and at high risk of a first cardiovascular event, as an adjunct to diet (see section 5.1). Secondary prevention Reduction of cardiovascular mortality and morbidity in patients with a history of myocardial infarction (MI) or unstable angina pectoris and with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors (see section 5.1). Post transplantation Reduction of post transplantation hyperlipidaemia in patients receiving immunosuppressive therapy following solid organ transplantation (see sections 4.2, 4.5 and 5.1). 2 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Prior to initiating pravastatin tablets, secondary causes of hypercholesterolaemia সম্পূর্ণ নথি পড়ুন